Roche Warns US Investment at Risk From Trump Drug Price Plan (1)

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trumpimplements an executive order to cut prescription drug costs.

Last month, Roche said it planned to invest $50 billion in pharmaceuticals and diagnostics in the US over the next five years, creating more than 12,000 jobs. That pledge came after Trump threatened tariffs on pharmaceutical imports, citing companies’ reliance on manufacturing sites around the world to supply the US.

Trump signed an executive order Monday asking drugmakers to lower prices voluntarily or else face regulatory measures.

“Should the proposed EO go into effect, Roche’s ...